An Invitation to Support Cancer Immunotherapy Research
The Center for Cancer Immunotherapy and Immunobiology (CCII) at Kyoto University was established on April 1, 2020, as the first Japanese comprehensive research institute dedicated to cancer immunotherapy. With the shared aspiration of achieving what has long been humanity’s greatest hope —the complete cure of cancer— our team is fully committed to advancing both clinical and fundamental research.
Your generous contributions play an essential role in sustaining and accelerating our mission. Donations are used with the utmost care to support our research activities, including the development of state‑of‑the‑art research facilities, the recruitment and retention of exceptional researchers, the organization of international symposia, and the dissemination of our scientific achievements worldwide.
We sincerely ask for your warm support in helping us drive forward the future of cancer immunotherapy.
For further information on how to make a donation, please click here
Tasuku Honjo
CCII Director
Donations and External Funding for CCII
Public sector research in postwar Japan has been almost entirely funded through government grants. It is only over the past decades that donations from individuals or corporations in support of basic science have been increasing. CCII has been made possible, in part, by private donations and our goal is to increase funding through external donations over time, thus enabling the center to support a diverse set of research efforts, including long-term basic science.
News
June 24, 2020
Donation by Mr. Tadashi Yanai of Fast Retailing Co. to support biomedical research at Kyoto University
Major donation by one of Japan’s foremost entrepreneurs aims at supporting groundbreaking research in cancer immunology and regenerative medicine at Kyoto University.
December 9, 2022
Donation from JCR Pharma Ltd.
Donation from JCR Pharma Ltd. to the “Tasuku Honjo Volunteer Fund” and the “Cancer Immunotherapy Research Fund” through a third-party allocation of treasury shares.
May 22, 2022
Groundbreaking Ceremony for the Bristol Myers Squibb Building, the new home for CCII
The building will be constructed based on a donation of JPY 5.5 billion (US$ 53 million) from Bristol-Myers Squibb K.K., in addition to a grant from the Japanese government.
How You Can Support Us
❶ Making a Donation per Payment Slip
Please contact the below Secretariat of the “Cancer Immunotherapy Research Fund”. Please convey your name, address and telephone number and we will send you a payment slip. (You can also complete the payment at a post office or bank counter.)
Please feel free to contact us with any inquiries regarding your donation.
Contact: CCII Fundraising Office
cirf-kikin@mail2.adm.kyoto-u.ac.jp
+81 75 7535855
❷ Making a Donation via the “Kyoto University Fund” Website
The Kyoto University Fund “Cancer Immunotherapy Research Fund”
Support this project with a donation >
